Determination of glycine transporter opens new avenues in development of psychiatric drugs

Glycine can stimulate or inhibit neurons in the brain, thereby controlling complex functions. Unraveling the three-dimensional structure of the glycine transporter, researchers have now come a big step closer to understanding the regulation of glycine in the brain. These results open up opportunities to find effective drugs that inhibit GlyT1 function, with major implications for the treatment of schizophrenia and other mental disorders.

Source: sciencedaily.com

Related posts

Non-stop flight: 4,200 km transatlantic flight of the Painted Lady butterfly mapped

Your future medications could be personalized for you on a 3D printer

Next platform for brain-inspired computing